Overview

A Prospective Observational Registry of Primary Headache Patients Treated With Ausanil

Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This study is an observational study with the primary objective to assess the safety and tolerability of Ausanil in the treatment of primary headache disorders. The secondary objective is to assess headache pain, functional outcome, time loss to headache and patient satisfaction with Ausanil treatment.
Details
Lead Sponsor:
VR1 Corporation